Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4522871
Max Phase: Preclinical
Molecular Formula: C23H24N6O3
Molecular Weight: 432.48
Molecule Type: Unknown
Associated Items:
ID: ALA4522871
Max Phase: Preclinical
Molecular Formula: C23H24N6O3
Molecular Weight: 432.48
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCn1nc(C)cc1C(=O)/N=c1\[nH]c2cc(C(N)=O)ccc2n1C[C@@H](O)c1ccccc1
Standard InChI: InChI=1S/C23H24N6O3/c1-3-29-19(11-14(2)27-29)22(32)26-23-25-17-12-16(21(24)31)9-10-18(17)28(23)13-20(30)15-7-5-4-6-8-15/h4-12,20,30H,3,13H2,1-2H3,(H2,24,31)(H,25,26,32)/t20-/m1/s1
Standard InChI Key: NMXJYHHOVIHSBO-HXUWFJFHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 432.48 | Molecular Weight (Monoisotopic): 432.1910 | AlogP: 2.07 | #Rotatable Bonds: 6 |
Polar Surface Area: 131.29 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.83 | CX LogP: 1.35 | CX LogD: 1.35 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.43 | Np Likeness Score: -1.67 |
1. Zhang H, You QD, Xu XL.. (2020) Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective., 63 (8): [PMID:31820978] [10.1021/acs.jmedchem.9b01039] |
2. Liu Y, Lu X, Qin N, Qiao Y, Xing S, Liu W, Feng F, Liu Z, Sun H.. (2021) STING, a promising target for small molecular immune modulator: A review., 211 [PMID:33360799] [10.1016/j.ejmech.2020.113113] |
3. Niu J, Bai H, Li Z, Gao Y, Zhang Y, Wang X, Yang Y, Xu Y, Geng M, Xie Z, Zhou B.. (2022) Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration., 238 [PMID:35671593] [10.1016/j.ejmech.2022.114482] |
4. Jeon MJ, Lee H, Lee J, Baek SY, Lee D, Jo S, Lee JY, Kang M, Jung HR, Han SB, Kim NJ, Lee S, Kim H.. (2022) Development of Potent Immune Modulators Targeting Stimulator of Interferon Genes Receptor., 65 (7.0): [PMID:35315650] [10.1021/acs.jmedchem.1c01795] |
Source(1):